SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-23-092432
Filing Date
2023-04-05
Accepted
2023-04-05 17:15:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B d410363d8a12b.htm 8-A12B 15794
  Complete submission text file 0001193125-23-092432.txt   16896
Mailing Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-38890 | Film No.: 23803485
SIC: 2836 Biological Products, (No Diagnostic Substances)